Close Menu

ChIP

The companies will combine their respective technologies to develop epigenetic assays for cancer patient stratification and personalized treatment.

Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.

A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

NEW YORK (GenomeWeb) — Researchers from the University of Washington have won $233,077 from the National Institute of General Medical Sciences to develop a novel chromatin immunoprecipitation platform, PIXUL-ChIP, that will integrate sample harvesting and chromatin shearing with immunoprecipitati

WaferGen Biosystems said this week that the Salk Institute for Biological Studies has established a nano-qPCR core laboratory that will feature a WaferGen SmartChip system for high-throughput, real-time PCR studies.

NEW YORK (GenomeWeb News) – A transcription factor called ELF5 may be a main determinant of breast cancer type, a team of Australian researchers reported in PLOS Biology last night.

NEW YORK (GenomeWeb News) – An international collaboration involving more than 400 researchers working to characterize gene regulatory networks in the human genome is publishing dozens of new studies this week.

NEW YORK (GenomeWeb News) – Colon cancers carry a telltale set of epigenetic enhancer sites that appear to mediate gene expression shifts in the disease, according to a new online study in Science.

The method, dubbed single-tube linear DNA amplification, or LinDA, is expected to facilitate genome-wide profiling of transcription factors and chromatin analyses using DNA obtained from just a few hundred cells.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.